Tags : Metastatic Urothelial Carcinoma

Merck KGaA and Pfizer Report Results of Bavencio (avelumab) in

Shots: The P-III JAVELIN Bladder 100 study involves assessing of Bavencio + best supportive care (BSC) vs BSC monothx in 700 patients with LA or mUC whose disease did not progress after completion of 1L Pt-chemotherapy The study resulted in improvement in OS with consistent safety results and will be shared with the US FDA […]Read More